3013-82-9

Basic information

• Product Name: N,N,9-trimethyl-9H-purin-6-amine
• CAS NO: 3013-82-9
• Molecular Formula: C₈H₁₁N₅
• Molecular Weight: 177.2064
• Mol File: 3013-82-9.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 337.5°C at 760 mmHg
• Flash Point: 157.9°C
• Density: 1.28g/cm³
• Vapor Pressure: 0.000104mmHg at 25°C
• Refractive Index: 1.661
• CAS DataBase Reference: N,N,9-trimethyl-9H-purin-6-amine(CAS DataBase Reference)
• NIST Chemistry Reference: N,N,9-trimethyl-9H-purin-6-amine(3013-82-9)
• EPA Substance Registry System: N,N,9-trimethyl-9H-purin-6-amine(3013-82-9)

Safety Data

• Hazardous Substances Data: 3013-82-9(Hazardous Substances Data)

Upstream product

• 2346-74-9 6-chloro-9-methyl-9H-purine 
• 124-40-3 dimethyl amine 
• 938-55-6 6-Dimethylaminopurine 
• 74-88-4 methyl iodide 
• 158782-61-7 9-methyl-6-(1,2,4-triazol-4-yl)purine 
• 1188-33-6 N,N-dimethylformamide diethyl diacetal 
• 700-00-5 3-methyladenine 
• 87-42-3 6-chloropurine 
• 52602-68-3 6-chloro-N⁴-methylpyrimidine-4,5-diamine 

Downstream Products

• 100-22-1 N,N,N',N'-tetramethyl-para-semiquinonediimine 
• 20427-22-9 9-methylpurine 
• 875-31-0 9-methylhypoxanthine 

Relevant articles and documents

-

-

A new approach to the synthesis of N,N-dialkyladenine derivatives

N,N-Dialkyladenine derivatives were prepared by two different reaction sequences starting from 5-amino-4-cyanoformimidoylimidazoles. When these imidazoles were treated with dimethylformamide diethyl acetal, a 5-aminomethyleneamino-4-cyanoformimidoylimidazole was isolated and evolved to the N,N-dialkyladenine in the presence of a secondary alkylamine. The same purine structure was isolated when the 5-amino-4-cyanoformimidoylimidazole was first treated with a secondary amine to give a stable 4-amidino-5- aminoimidazole. The desired product was generated when the 4-amidino-5- aminoimidazole was combined with dimethylformamide diethyl acetal, at room temperature. Wiley-VCH Verlag GmbH & Co. KGaA, 2007.

Efficient conversion of 6-aminopurines and nucleosides into 6-substituted analogues via novel 6-(1,2,4-triazol-4-yl)purine derivatives

-